Lista de obras - Carlos J Alméciga-Díaz

A perspective on research, diagnosis, and management of lysosomal storage disorders in Colombia

scientific article published on 28 March 2020

Adeno-associated virus gene transfer in Morquio A disease - effect of promoters and sulfatase-modifying factor 1.

artículo científico publicado en 2010

Advances in the Development of Pharmacological Chaperones for the Mucopolysaccharidoses

artículo científico publicado en 2019

Anaerobic sulfatase maturase AslB from Escherichia coli activates human recombinant iduronate-2-sulfate sulfatase (IDS) and N-acetylgalactosamine-6-sulfate sulfatase (GALNS).

artículo científico publicado en 2017

CRISPR/nCas9-Based Genome Editing on GM2 Gangliosidoses Fibroblasts via Non-Viral Vectors

artículo científico publicado en 2022

Characterization of Human Recombinant N-Acetylgalactosamine-6-Sulfate Sulfatase Produced in Pichia pastoris as Potential Enzyme for Mucopolysaccharidosis IVA Treatment

scientific article published on 05 April 2019

Characterization of a new bacteriocin from Lactobacillus plantarum LE5 and LE27 isolated from ensiled corn

artículo científico publicado en 2014

Computational analysis of human N-acetylgalactosamine-6-sulfate sulfatase enzyme: an update in genotype-phenotype correlation for Morquio A

artículo científico publicado en 2014

Computational analysis of the fructosyltransferase enzymes in plants, fungi and bacteria

scientific article published on 12 June 2011

Current and emerging treatments and surgical interventions for Morquio A syndrome: a review

artículo científico publicado en 2012

Design and applications of gene therapy vectors for mucopolysaccharidosis in Colombia

scientific article published on 02 July 2019

Development of Bone Targeting Drugs.

artículo científico publicado en 2017

Effect of culture conditions and signal peptide on production of human recombinant N-acetylgalactosamine-6-sulfate sulfatase in Escherichia coli BL21.

artículo científico publicado en 2013

Effect of elongation factor 1alpha promoter and SUMF1 over in vitro expression of N-acetylgalactosamine-6-sulfate sulfatase

artículo científico publicado en 2008

Enzyme replacement therapy for Morquio A: an active recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in Escherichia coli BL21.

artículo científico publicado en 2010

Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations.

artículo científico publicado en 2015

Evaluation of toxicity and degradation of a chlorophenol mixture by the laccase produced by Trametes pubescens

article

Fructooligosaccharides metabolism and effect on bacteriocin production in Lactobacillus strains isolated from ensiled corn and molasses

artículo científico publicado en 2012

GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies

scientific article published on 27 August 2020

Gene cloning and enzyme structure modeling of the Aspergillus oryzae N74 fructosyltransferase

artículo científico publicado en 2010

Gene therapy for Mucopolysaccharidoses.

artículo científico publicado en 2017

Generation of an induced pluripotent stem cell line (TRNDi005-A) from a Mucopolysaccharidosis Type IVA (MPS IVA) patient carrying compound heterozygous p.R61W and p.WT405del mutations in the GALNS gene

scientific article published on 15 February 2019

Human recombinant lysosomal enzymes produced in microorganisms.

artículo científico

Human recombinant lysosomal β-Hexosaminidases produced in Pichia pastoris efficiently reduced lipid accumulation in Tay-Sachs fibroblasts

artículo científico publicado en 2020

Identification of Ezetimibe and Pranlukast as Pharmacological Chaperones for the Treatment of the Rare Disease Mucopolysaccharidosis Type IVA

artículo científico publicado en 2019

Identification of the iduronate-2-sulfatase proteome in wild-type mouse brain

artículo científico publicado en 2019

Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome.

artículo científico publicado en 2015

Improvement in the production of the human recombinant enzyme N-acetylgalactosamine-6-sulfatase (rhGALNS) in Escherichia coli using synthetic biology approaches.

artículo científico publicado en 2017

In Silico Analysis of the Structure of Fungal Fructooligosaccharides-Synthesizing Enzymes.

artículo científico publicado en 2016

Lysosomal storage diseases: current therapies and future alternatives

artículo científico publicado en 2020

Media improvement for 10 L bioreactor production of rPOXA 1B laccase by P. pastoris

scientific article published on 11 November 2019

Mucopolysaccharidosis IVA and glycosaminoglycans.

artículo científico publicado en 2016

Native and heterologous production of bacteriocins from gram-positive microorganisms.

artículo científico

Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease

artículo científico publicado en 2018

Plackett-Burman Design for rGILCC1 Laccase Activity Enhancement in Pichia pastoris: Concentrated Enzyme Kinetic Characterization

artículo científico publicado en 2017

Production and characterization of a human lysosomal recombinant iduronate-2-sulfatase produced in Pichia pastoris.

artículo científico publicado en 2018

Production of Recombinant Trichoderma reesei Cellobiohydrolase II in a New Expression System Based on Wickerhamomyces anomalus.

artículo científico publicado en 2017

Production of Trametes pubescens laccase under submerged and semi-solid culture conditions on agro-industrial wastes

artículo científico publicado en 2013

Production of human recombinant phenylalanine hydroxylase in Lactobacillus plantarum for gastrointestinal delivery.

artículo científico publicado en 2017

Recent trends in fructooligosaccharides production.

artículo científico publicado en 2009

Recombinant human N-acetylgalactosamine-6-sulfate sulfatase (GALNS) produced in the methylotrophic yeast Pichia pastoris

artículo científico publicado en 2016

Research, diagnosis and education in inborn errors of metabolism in Colombia: 20 years' experience from a reference center

artículo científico publicado en 2018

Solvent extraction of organic acids from stillage for its re-use in ethanol production process

artículo científico publicado en 2009

Systems biology study of mucopolysaccharidosis using a human metabolic reconstruction network.

artículo científico publicado en 2015

Tailoring the AAV2 capsid vector for bone-targeting

artículo científico publicado en 2018

Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments

artículo científico publicado en 2019

Therapies for the bone in mucopolysaccharidoses

artículo científico publicado en 2015

Therapies of mucopolysaccharidosis IVA (Morquio A syndrome).

artículo científico publicado en 2013

Lista de obras de Carlos J Alméciga-Díaz

A perspective on research, diagnosis, and management of lysosomal storage disorders in Colombia

Adeno-associated virus gene transfer in Morquio A disease - effect of promoters and sulfatase-modifying factor 1.

Advances in the Development of Pharmacological Chaperones for the Mucopolysaccharidoses

Anaerobic sulfatase maturase AslB from Escherichia coli activates human recombinant iduronate-2-sulfate sulfatase (IDS) and N-acetylgalactosamine-6-sulfate sulfatase (GALNS).

CRISPR/nCas9-Based Genome Editing on GM2 Gangliosidoses Fibroblasts via Non-Viral Vectors

Characterization of Human Recombinant N-Acetylgalactosamine-6-Sulfate Sulfatase Produced in Pichia pastoris as Potential Enzyme for Mucopolysaccharidosis IVA Treatment

Characterization of a new bacteriocin from Lactobacillus plantarum LE5 and LE27 isolated from ensiled corn

Computational analysis of human N-acetylgalactosamine-6-sulfate sulfatase enzyme: an update in genotype-phenotype correlation for Morquio A

Computational analysis of the fructosyltransferase enzymes in plants, fungi and bacteria

Current and emerging treatments and surgical interventions for Morquio A syndrome: a review

Design and applications of gene therapy vectors for mucopolysaccharidosis in Colombia

Development of Bone Targeting Drugs.

Effect of culture conditions and signal peptide on production of human recombinant N-acetylgalactosamine-6-sulfate sulfatase in Escherichia coli BL21.

Effect of elongation factor 1alpha promoter and SUMF1 over in vitro expression of N-acetylgalactosamine-6-sulfate sulfatase

Enzyme replacement therapy for Morquio A: an active recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in Escherichia coli BL21.

Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations.

Evaluation of toxicity and degradation of a chlorophenol mixture by the laccase produced by Trametes pubescens

Fructooligosaccharides metabolism and effect on bacteriocin production in Lactobacillus strains isolated from ensiled corn and molasses

GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies

Gene cloning and enzyme structure modeling of the Aspergillus oryzae N74 fructosyltransferase

Gene therapy for Mucopolysaccharidoses.

Generation of an induced pluripotent stem cell line (TRNDi005-A) from a Mucopolysaccharidosis Type IVA (MPS IVA) patient carrying compound heterozygous p.R61W and p.WT405del mutations in the GALNS gene

Human recombinant lysosomal enzymes produced in microorganisms.

Human recombinant lysosomal β-Hexosaminidases produced in Pichia pastoris efficiently reduced lipid accumulation in Tay-Sachs fibroblasts

Identification of Ezetimibe and Pranlukast as Pharmacological Chaperones for the Treatment of the Rare Disease Mucopolysaccharidosis Type IVA

Identification of the iduronate-2-sulfatase proteome in wild-type mouse brain

Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome.

Improvement in the production of the human recombinant enzyme N-acetylgalactosamine-6-sulfatase (rhGALNS) in Escherichia coli using synthetic biology approaches.

In Silico Analysis of the Structure of Fungal Fructooligosaccharides-Synthesizing Enzymes.

Lysosomal storage diseases: current therapies and future alternatives

Media improvement for 10 L bioreactor production of rPOXA 1B laccase by P. pastoris

Mucopolysaccharidosis IVA and glycosaminoglycans.

Native and heterologous production of bacteriocins from gram-positive microorganisms.

Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease

Plackett-Burman Design for rGILCC1 Laccase Activity Enhancement in Pichia pastoris: Concentrated Enzyme Kinetic Characterization

Production and characterization of a human lysosomal recombinant iduronate-2-sulfatase produced in Pichia pastoris.

Production of Recombinant Trichoderma reesei Cellobiohydrolase II in a New Expression System Based on Wickerhamomyces anomalus.

Production of Trametes pubescens laccase under submerged and semi-solid culture conditions on agro-industrial wastes

Production of human recombinant phenylalanine hydroxylase in Lactobacillus plantarum for gastrointestinal delivery.

Recent trends in fructooligosaccharides production.

Recombinant human N-acetylgalactosamine-6-sulfate sulfatase (GALNS) produced in the methylotrophic yeast Pichia pastoris

Research, diagnosis and education in inborn errors of metabolism in Colombia: 20 years' experience from a reference center

Solvent extraction of organic acids from stillage for its re-use in ethanol production process

Systems biology study of mucopolysaccharidosis using a human metabolic reconstruction network.

Tailoring the AAV2 capsid vector for bone-targeting

Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments

Therapies for the bone in mucopolysaccharidoses

Therapies of mucopolysaccharidosis IVA (Morquio A syndrome).